Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 13 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 69 most recent Form 4 transactions.
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 29,074 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 29,074 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 26,152 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 84,051 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 119,969 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 56,579 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 2,328 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 5,032 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 3,421 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 43,810 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 238,339 | — | — | -100.0% | Open the original filing on SEC.gov |
| Nov 25, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 4,739 | — | — | — | Open the original filing on SEC.gov |
| Nov 25, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 3,527 | — | — | — | Open the original filing on SEC.gov |
| Nov 25, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 4,284 | — | — | — | Open the original filing on SEC.gov |
| Nov 25, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 43,064 | — | — | — | Open the original filing on SEC.gov |
| Nov 25, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 94,268 | — | — | — | Open the original filing on SEC.gov |
| Nov 25, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 2,796 | — | — | — | Open the original filing on SEC.gov |
| Nov 25, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 4,739 | $21.10 | $100K | +1.7% | Open the original filing on SEC.gov |
| Nov 25, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 94,268 | $0.615 | $58K | +51.5% | Open the original filing on SEC.gov |
| Nov 25, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 2,796 | $0.615 | $1.7K | +1.6% | Open the original filing on SEC.gov |
| Nov 25, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 4,284 | $21.09 | $90.3K | +2.4% | Open the original filing on SEC.gov |
| Nov 25, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 43,064 | $6.36 | $274.1K | +32.4% | Open the original filing on SEC.gov |
| Nov 25, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 3,527 | $28.35 | $100K | +2.7% | Open the original filing on SEC.gov |
| Nov 17, 2025 | AKRO | Akero Therapeutics, Inc. | GGIFT | 37,100 | — | — | -22.3% | Open the original filing on SEC.gov |
| Oct 7, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| Oct 7, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 1,037 | $46.82 | $48.6K | -0.6% | Open the original filing on SEC.gov |
| Oct 7, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 11,463 | $46.01 | $527.4K | -6.4% | Open the original filing on SEC.gov |
| Oct 7, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 12,500 | $28.35 | $354.4K | +7.5% | Open the original filing on SEC.gov |
| Sep 11, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 553 | $43.02 | $23.8K | -0.3% | Open the original filing on SEC.gov |
| Sep 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 5,161 | — | — | — | Open the original filing on SEC.gov |
| Sep 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 295 | — | — | — | Open the original filing on SEC.gov |
| Sep 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 7,044 | — | — | — | Open the original filing on SEC.gov |
| Sep 8, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 34 | $44.88 | $1.5K | <0.1% | Open the original filing on SEC.gov |
| Sep 8, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 12,466 | $44.17 | $550.6K | -6.9% | Open the original filing on SEC.gov |
| Sep 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 295 | $28.35 | $8.4K | +0.2% | Open the original filing on SEC.gov |
| Sep 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 5,161 | $6.36 | $32.8K | +3.0% | Open the original filing on SEC.gov |
| Sep 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 7,044 | $21.09 | $148.6K | +4.2% | Open the original filing on SEC.gov |
| Aug 5, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| Aug 5, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 6,962 | $49.49 | $344.6K | -4.0% | Open the original filing on SEC.gov |
| Aug 5, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 5,538 | $49.07 | $271.7K | -3.1% | Open the original filing on SEC.gov |
| Aug 5, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 12,500 | $21.09 | $263.6K | +7.5% | Open the original filing on SEC.gov |
| Jul 7, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| Jul 7, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 41 | $52.62 | $2.2K | <0.1% | Open the original filing on SEC.gov |
| Jul 7, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 1,825 | $52.00 | $94.9K | -1.1% | Open the original filing on SEC.gov |
| Jul 7, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 10,634 | $50.93 | $541.6K | -5.9% | Open the original filing on SEC.gov |
| Jul 7, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 12,500 | $21.09 | $263.6K | +7.5% | Open the original filing on SEC.gov |
| Jun 30, 2025 | AKRO | Akero Therapeutics, Inc. | AGRANT | 890 | $23.87 | $21.2K | +0.5% | Open the original filing on SEC.gov |
| Jun 18, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 1,129 | $54.84 | $61.9K | -0.7% | Open the original filing on SEC.gov |
| Jun 10, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 2,358 | $54.00 | $127.3K | -1.4% | Open the original filing on SEC.gov |
| Jun 6, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 24,611 | — | — | — | Open the original filing on SEC.gov |
| Jun 6, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 389 | — | — | — | Open the original filing on SEC.gov |
| Jun 6, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 25,000 | $55.04 | $1.4M | -12.8% | Open the original filing on SEC.gov |
| Jun 6, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 389 | $21.10 | $8.2K | +0.2% | Open the original filing on SEC.gov |
| Jun 6, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 24,611 | $21.09 | $519K | +14.5% | Open the original filing on SEC.gov |
| Jun 5, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 3,150 | $53.84 | $169.6K | -1.8% | Open the original filing on SEC.gov |
| Jun 5, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 9,350 | $53.37 | $499K | -5.1% | Open the original filing on SEC.gov |
| Jun 5, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 12,500 | $21.10 | $263.8K | +7.4% | Open the original filing on SEC.gov |
| May 6, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| May 6, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 300 | $44.50 | $13.4K | -0.2% | Open the original filing on SEC.gov |
| May 6, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 8,650 | $43.87 | $379.5K | -4.8% | Open the original filing on SEC.gov |
| May 6, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 3,550 | $42.26 | $150K | -1.9% | Open the original filing on SEC.gov |
| May 6, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 12,500 | $21.10 | $263.8K | +7.4% | Open the original filing on SEC.gov |
| Apr 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 3,684 | — | — | — | Open the original filing on SEC.gov |
| Apr 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 2,566 | — | — | — | Open the original filing on SEC.gov |
| Apr 24, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 6,250 | $41.03 | $256.4K | -3.5% | Open the original filing on SEC.gov |
| Apr 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 6,250 | $21.10 | $131.9K | +3.7% | Open the original filing on SEC.gov |